A germline variant in the TP53 polyadenylation signal confers cancer susceptibility.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Stacey, Simon NSulem, Patrick
Jonasdottir, Aslaug
Masson, Gisli
Gudmundsson, Julius
Gudbjartsson, Daniel F
Magnusson, Olafur T
Gudjonsson, Sigurjon A
Sigurgeirsson, Bardur
Thorisdottir, Kristin
Ragnarsson, Rafn
Mayordomo, José I
Olafsson, Jon H
Kong, Augustine
Thorsteinsdottir, Unnur
Rafnar, Thorunn
Stefansson, Kari
Benediktsdottir, Kristrun R
Nexø, Bjørn A
Tjønneland, Anne
Overvad, Kim
Rudnai, Peter
Gurzau, Eugene
Koppova, Kvetoslava
Hemminki, Kari
Corredera, Cristina
Fuentelsaz, Victoria
Grasa, Pilar
Navarrete, Sebastian
Fuertes, Fernando
García-Prats, Maria D
Sanambrosio, Enrique
Panadero, Angeles
De Juan, Ana
Garcia, Almudena
Rivera, Fernando
Planelles, Dolores
Soriano, Virtudes
Requena, Celia
Aben, Katja K
van Rossum, Michelle M
Cremers, Ruben G H M
van Oort, Inge M
van Spronsen, Dick-Johan
Schalken, Jack A
Peters, Wilbert H M
Helfand, Brian T
Donovan, Jenny L
Hamdy, Freddie C
Badescu, Daniel
Codreanu, Ovidiu
Jinga, Mariana
Csiki, Irma E
Constantinescu, Vali
Badea, Paula
Mates, Ioan N
Dinu, Daniela E
Constantin, Adrian
Mates, Dana
Kristjansdottir, Sjofn
Agnarsson, Bjarni A
Jonsson, Eirikur
Barkardottir, Rosa B
Einarsson, Gudmundur V
Sigurdsson, Fridbjorn
Moller, Pall H
Stefansson, Tryggvi
Valdimarsson, Trausti
Johannsson, Oskar T
Sigurdsson, Helgi
Jonsson, Thorvaldur
Jonasson, Jon G
Tryggvadottir, Laufey
Rice, Terri
Hansen, Helen M
Xiao, Yuanyuan
Lachance, Daniel H
O Neill, Brian Patrick
Kosel, Matthew L
Decker, Paul A
Thorleifsson, Gudmar
Johannsdottir, Hrefna
Helgadottir, Hafdis T
Sigurdsson, Asgeir
Steinthorsdottir, Valgerdur
Lindblom, Annika
Sandler, Robert S
Keku, Temitope O
Banasik, Karina
Jørgensen, Torben
Witte, Daniel R
Hansen, Torben
Pedersen, Oluf
Jinga, Viorel
Neal, David E
Catalona, William J
Wrensch, Margaret
Wiencke, John
Jenkins, Robert B
Nagore, Eduardo
Vogel, Ulla
Kiemeney, Lambertus A
Kumar, Rajiv
Issue Date
2011-11
Metadata
Show full item recordCitation
Nat. Genet. 2011, 43(11):1098-103Abstract
To identify new risk variants for cutaneous basal cell carcinoma, we performed a genome-wide association study of 16 million SNPs identified through whole-genome sequencing of 457 Icelanders. We imputed genotypes for 41,675 Illumina SNP chip-typed Icelanders and their relatives. In the discovery phase, the strongest signal came from rs78378222[C] (odds ratio (OR) = 2.36, P = 5.2 × 10(-17)), which has a frequency of 0.0192 in the Icelandic population. We then confirmed this association in non-Icelandic samples (OR = 1.75, P = 0.0060; overall OR = 2.16, P = 2.2 × 10(-20)). rs78378222 is in the 3' untranslated region of TP53 and changes the AATAAA polyadenylation signal to AATACA, resulting in impaired 3'-end processing of TP53 mRNA. Investigation of other tumor types identified associations of this SNP with prostate cancer (OR = 1.44, P = 2.4 × 10(-6)), glioma (OR = 2.35, P = 1.0 × 10(-5)) and colorectal adenoma (OR = 1.39, P = 1.6 × 10(-4)). However, we observed no effect for breast cancer, a common Li-Fraumeni syndrome tumor (OR = 1.06, P = 0.57, 95% confidence interval 0.88-1.27).Description
To access publisher full text version of this article. Please click on the hyperlink in Additional Links field.Additional Links
http://dx.doi.org/10.1038/ng.926http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3263694/
Rights
Archived with thanks to Nature geneticsae974a485f413a2113503eed53cd6c53
10.1038/ng.926
Scopus Count
Collections
Related articles
- Low penetrance susceptibility to glioma is caused by the TP53 variant rs78378222.
- Authors: Enciso-Mora V, Hosking FJ, Di Stefano AL, Zelenika D, Shete S, Broderick P, Idbaih A, Delattre JY, Hoang-Xuan K, Marie Y, Labussière M, Alentorn A, Ciccarino P, Rossetto M, Armstrong G, Liu Y, Gousias K, Schramm J, Lau C, Hepworth SJ, Schoemaker M, Strauch K, Müller-Nurasyid M, Schreiber S, Franke A, Moebus S, Eisele L, Swerdlow A, Simon M, Bondy M, Lathrop M, Sanson M, Houlston RS
- Issue date: 2013 May 28
- A novel TP53 variant (rs78378222 A > C) in the polyadenylation signal is associated with increased cancer susceptibility: evidence from a meta-analysis.
- Authors: Wang Y, Wu XS, He J, Ma T, Lei W, Shen ZY
- Issue date: 2016 May 31
- A functional germline variant in the P53 polyadenylation signal and risk of esophageal squamous cell carcinoma.
- Authors: Zhou L, Yuan Q, Yang M
- Issue date: 2012 Sep 15
- Rare variants in TP53 and susceptibility to neuroblastoma.
- Authors: Diskin SJ, Capasso M, Diamond M, Oldridge DA, Conkrite K, Bosse KR, Russell MR, Iolascon A, Hakonarson H, Devoto M, Maris JM
- Issue date: 2014 Apr
- Rare germline variant (rs78378222) in the TP53 3' UTR: Evidence for a new mechanism of cancer predisposition in Li-Fraumeni syndrome.
- Authors: Macedo GS, Araujo Vieira I, Brandalize AP, Giacomazzi J, Inez Palmero E, Volc S, Rodrigues Paixão-Côrtes V, Caleffi M, Silva Alves M, Achatz MI, Hainaut P, Ashton-Prolla P
- Issue date: 2016 Mar